Prevalence and risk factors of adverse events during treatment of drug resistant tuberculosis in a setting of high human immunodeficiency virus co-infection in Namibia : 2009-10
Magister Public Health - MPH === Namibia is currently coping with a dual burden of human immunodeficiency (HIV) and HIV-associated tuberculosis (TB). In 2010, HIV prevalence was 18.8%, the TB case notification rate was 634 per 100,000 population, while TB/HIV co-infection was 58% in 2009. There were...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en |
| Published: |
University of the Western Cape
2015
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/11394/4625 |